You just read:

APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease

News provided by

APRINOIA Therapeutics Inc.

16 Jan, 2018, 07:09 GMT